664. Are Thousands of Medical Cures Hiding in Plain Sight?

664. Are Thousands of Medical Cures Hiding in Plain Sight?

Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle.

  • SOURCES:
    • Chris Snyder, professor of economics at Dartmouth College.
    • David Fajgenbaum, co-founder and president of Every Cure, physician-scientist at the University of Pennsylvania.
    • Heather Stone, health science policy analyst at the Food & Drug Administration.
    • Sarrin Chethik, senior policy analyst at the Market Shaping Accelerator.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Avsnitt(890)

659. Can Marty Makary Fix the F.D.A.?

659. Can Marty Makary Fix the F.D.A.?

It regulates 20 percent of the U.S. economy, and its commissioner has an aggressive agenda — faster drug approvals, healthier food, cures for diabetes and cancer. How much can he deliver? (Part two of...

16 Jan 55min

658. This Is Your Brain on Supplements

658. This Is Your Brain on Supplements

We all want to stay sharp, and forestall the cognitive effects of aging. But do brain supplements actually work? Are they safe? And why doesn’t the F.D.A. even know what’s in them? (Part one of “The F...

9 Jan 53min

Are Personal Finance Gurus Giving You Bad Advice? (Update)

Are Personal Finance Gurus Giving You Bad Advice? (Update)

One Yale economist certainly thinks so. But even if he’s right, are economists any better? We find out, in this update of a 2022 episode. SOURCES:James Choi, professor of finance at the Yale School of...

2 Jan 1h

Are You Ready for a Fresh Start? (Update)

Are You Ready for a Fresh Start? (Update)

Behavioral scientists have been exploring whether a psychological reset can lead to lasting change. In this update of a 2021 episode, we survey evidence from the London Underground, Major League Baseb...

30 Dec 202542min

Are the Rich Really Less Generous Than the Poor? (Update)

Are the Rich Really Less Generous Than the Poor? (Update)

A series of academic studies suggest that the wealthy are, to put it bluntly, selfish jerks. It’s an easy narrative to embrace — but is it true? As part of GiveDirectly’s “Pods Fight Poverty” campaign...

26 Dec 202543min

657. Whose “Messiah” Is It Anyway?

657. Whose “Messiah” Is It Anyway?

All sorts of people have put their mark on Messiah, and it has been a hit for nearly 300 years. How can a single piece of music thrive in so many settings? You could say it’s because Handel really kne...

19 Dec 202548min

Who Pays for “Messiah”?

Who Pays for “Messiah”?

In the 18th century, Handel relied on royal patronage. Today, it’s donors like Gary Parr who keep the music playing. In this bonus episode of our “Making Messiah” series, Parr breaks down the economic...

17 Dec 202542min

656. How Handel Got His Mojo Back

656. How Handel Got His Mojo Back

When he wrote Messiah (in 24 days), Handel was past his prime and nearly broke. One night in Dublin changed all that. (Part two of “Making Messiah.”) SOURCES:Charles King, political scientist at Georg...

12 Dec 202557min

Populärt inom Samhälle & Kultur

podme-dokumentar
en-mork-historia
p3-dokumentar
gynning-berg
mardromsgasten
aftonbladet-krim
badfluence
nemo-moter-en-van
creepypodden-med-jack-werner
skaringer-nessvold
killradet
hor-har
flashback-forever
blenda-2
p1-dokumentar
vad-blir-det-for-mord
aftonbladet-daily
historiska-brott
p3-historia
rss-korten-pa-bordet-2